Literature DB >> 12072872

Endogenous pulmonary surfactant metabolism is not affected by mode of ventilation in premature infants with respiratory distress syndrome.

Assaad Merchak1, Daphne J Janssen, Kajsa Bohlin, Bruce W Patterson, Luc J Zimmermann, Virgilio P Carnielli, Aaron Hamvas.   

Abstract

OBJECTIVE: To determine if high frequency oscillatory ventilation (HFOV) decreases surfactant production in premature infants with respiratory distress syndrome (RDS). STUDY
DESIGN: We randomized 19 infants <28 weeks of gestation to either HFOV (n = 8) or conventional ventilation (CV, n = 11) at 24 hours of life. After a 24-hour continuous infusion of uniformly labeled carbon 13 glucose (U-(13)C(6)) glucose, we measured (13)C enrichment in surfactant phosphatidylcholine (PC) in tracheal aspirate samples using gas chromatography/mass spectrometry. We calculated the fractional synthetic rate (FSR) of surfactant PC from labeled glucose and its half-life of clearance (T(1/2)).
RESULTS: FSR did not differ between groups (4.7% +/- 2.7%/day CV vs 4.2% +/- 3.1%/day HFOV, P =.7). T(1/2) was 79 +/- 18 hours in the CV group and 76 +/- 23 hours in the HFOV group (P =.7). Neither degree of ventilatory support nor supplemental oxygen exposure correlated with surfactant metabolic indices. Three of 4 infants who died from RDS within the first month of life had a shorter T(1/2) than 14 of 15 infants who survived.
CONCLUSION: Surfactant metabolism is similar in preterm infants ventilated with HFOV and CV. Shortened surfactant half-life may characterize a subset of preterm infants with lethal RDS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072872     DOI: 10.1067/mpd.2002.124320

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  1 in total

1.  Decreased surfactant phosphatidylcholine synthesis in neonates with congenital diaphragmatic hernia during extracorporeal membrane oxygenation.

Authors:  Daphne J Janssen; Luc J Zimmermann; Paola Cogo; Aaron Hamvas; Kajsa Bohlin; Ingrid H Luijendijk; Darcos Wattimena; Virgilio P Carnielli; Dick Tibboel
Journal:  Intensive Care Med       Date:  2009-07-07       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.